Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway
Hormone and Metabolic Research · 01.05.2024 · 56 (05) · 381-391
DOI: 10.1055/a-2233-0245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.05.2024. Verfasst von Zhijun Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: MicroRNAs, Thyroid Cancer, Papillary, Thyroid Neoplasms, Cell Proliferation. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
CircRNAs have been found to participate in the progression of various tumors. In the present study, we aimed to clarify the role of hsa_circ_0092355 in papillary thyroid cancer (PTC) cell development. RT-qPCR was used to determine the expression of hsa_circ_0092355, miR-543, and PDE5A. PTC cell proliferation was ascertained via a cell colony formation assay and the CCK-8 test. Western blotting was performed to examine the expression levels of PDE5A and apoptosis-associated proteins (Bcl-2 and Bax) in PTC cells. A scratch wound assay was performed to measure the migration of PTC cells. A mouse xenograft test was performed to assess the effects of hsa_circ_0092355 in vivo. RIP and dual-luciferase reporter assays confirmed the association between miR-543 and hsa_circ_0092355 or PDE5A. Associations between miR-543, hsa_circ_0092355, and PDE5A were evaluated using Pearson’s correlation coefficient. Upregulation of hsa_circ_0092355 was observed in PTC tissues. The hsa_circ_0092355 knockdown blocked the proliferation and migration of PTC cells and induced apoptosis. Moreover, hsa_circ_0092355 knockdown blocked PTC xenograft tumor growth in vivo. The miR-543 inhibitor could reverse the changes induced by hsa_circ_0092355 knockdown by hsa_circ_0092355 targeting miR-543. Furthermore, miR-543 suppresses PTC progression by downregulating PDE5A expression. Our findings suggest that the PTC tumor promoter hsa_circ_0092355 may promote carcinogenesis by controlling the miR-543/PDE5A pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- General Surgery Department, Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan, Hubei, China.
- Nursing Department of General Surgery, Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan, Hubei, China.
- Pharmacy Department, Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan, Hubei, China.
- Department of Anesthesiology, Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan, Hubei, China.
Zitieren
APA
Sun, Z., Zhang, M., Ye, Y., & Yang, L. (2024). Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway. Hormone and Metabolic Research, 56(05), 381-391. https://doi.org/10.1055/a-2233-0245
Vancouver
Sun Z, Zhang M, Ye Y, Yang L. Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway. Hormone and Metabolic Research. 2024;56(05):381-391. doi:10.1055/a-2233-0245
BibTeX
@article{Sun2024,
author = {Sun, Zhijun and Zhang, Min and Ye, Yangmei and Yang, Leilei},
title = {Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {05},
pages = {381--391},
doi = {10.1055/a-2233-0245}
}
EUVIMED